127 related articles for article (PubMed ID: 38859837)
61. The lncRNA
Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
[TBL] [Abstract][Full Text] [Related]
62. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
63. Actin filament-associated protein 1-antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1-AS1/miR-133a-5p/ZIC2 axis.
Tang M; Wu H; Zhang H; Xu X; Jiang B; Chen Q; Wei Y; Qian H; Han L
J Gene Med; 2024 Jan; 26(1):e3654. PubMed ID: 38282153
[TBL] [Abstract][Full Text] [Related]
64. miR-145-5p Inhibits Neuroendocrine Differentiation and Tumor Growth by Regulating the SOX11/MYCN Axis in Prostate cancer.
Ji S; Shi Y; Yang L; Zhang F; Li Y; Xu F
Front Genet; 2022; 13():790621. PubMed ID: 35368699
[TBL] [Abstract][Full Text] [Related]
65. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
66. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
Yuan S; Bi J; Zhang Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):1-12. PubMed ID: 36734853
[TBL] [Abstract][Full Text] [Related]
67. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
68. Role of MicroRNAs in Neuroendocrine Prostate Cancer.
Sreekumar A; Saini S
Noncoding RNA; 2022 Mar; 8(2):. PubMed ID: 35447888
[TBL] [Abstract][Full Text] [Related]
69. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer.
Enriquez C; Cancila V; Ferri R; Sulsenti R; Fischetti I; Milani M; Ostano P; Gregnanin I; Mello-Grand M; Berrino E; Bregni M; Renne G; Tripodo C; Colombo MP; Jachetti E
Cancer Res; 2021 Aug; 81(16):4257-4274. PubMed ID: 34185677
[TBL] [Abstract][Full Text] [Related]
70. Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate
Zhou H; He Q; Li C; Alsharafi BLM; Deng L; Long Z; Gan Y
Front Cell Dev Biol; 2022; 10():955669. PubMed ID: 35938167
[TBL] [Abstract][Full Text] [Related]
71. LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer.
Jia Z; Li W; Bian P; Liu H; Pan D; Dou Z
Onco Targets Ther; 2020; 13():9365-9376. PubMed ID: 33061424
[TBL] [Abstract][Full Text] [Related]
72. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
[TBL] [Abstract][Full Text] [Related]
73. Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells.
Courel M; El Yamani FZ; Alexandre D; El Fatemi H; Delestre C; Montero-Hadjadje M; Tazi F; Amarti A; Magoul R; Chartrel N; Anouar Y
Eur J Cancer; 2014 Nov; 50(17):3039-49. PubMed ID: 25307750
[TBL] [Abstract][Full Text] [Related]
74. LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins.
Song Y; Du J; Lu P; Zou Q; Zeng S; Liu M; Hu X; Ma W; Lin H; Liu X; Niu F
Ann Transl Med; 2021 Nov; 9(21):1621. PubMed ID: 34926665
[TBL] [Abstract][Full Text] [Related]
75. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis.
Wei P; Yang J; Zhang D; Cui M; Li L
Onco Targets Ther; 2020; 13():4523-4531. PubMed ID: 32547083
[TBL] [Abstract][Full Text] [Related]
76. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Li YY; Li W; Chang GZ; Li YM
Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
[TBL] [Abstract][Full Text] [Related]
77. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF; Song LD; Xu Q; Zhan JF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
[TBL] [Abstract][Full Text] [Related]
78. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.
Liang H; Studach L; Hullinger RL; Xie J; Andrisani OM
Exp Cell Res; 2014 Jan; 320(2):188-99. PubMed ID: 24135225
[TBL] [Abstract][Full Text] [Related]
79. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy.
Peng D; Li W; Zhang B; Liu X
J Cell Mol Med; 2021 Sep; 25(17):8148-8158. PubMed ID: 34378314
[TBL] [Abstract][Full Text] [Related]
80. Long non-coding RNA DNMBP-AS1 promotes prostate cancer development by regulating LCLAT1.
Yin X; Wang S; Ge R; Chen J; Gao Y; Xu S; Yang T
Syst Biol Reprod Med; 2023 Apr; 69(2):142-152. PubMed ID: 36602957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]